Cargando…
Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches
BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative illness described predominantly by dementia. Even though Alzheimer’s disease has been known for over a century, its origin remains a mystery, and researchers are exploring many therapy options, including the cholinesterase technique. A decr...
Autores principales: | Zafar, Rehman, Naureen, Humaira, Zubair, Muhammad, Shahid, Khadija, Saeed Jan, Muhammad, Akhtar, Samar, Ahmad, Hammad, Waseem, Wajeeha, Haider, Ali, Ali, Saqib, Tariq, Muhammad, Sadiq, Abdul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232895/ https://www.ncbi.nlm.nih.gov/pubmed/34188447 http://dx.doi.org/10.2147/DDDT.S311619 |
Ejemplares similares
-
Prospective Evaluation
of an Amide-Based Zinc Scaffold
as an Anti-Alzheimer Agent: In Vitro, In
Vivo, and Computational Studies
por: Waseem, Wajeeha, et al.
Publicado: (2022) -
Synthesis, Structural Elucidation and Pharmacological Applications of Cu(II) Heteroleptic Carboxylates
por: Ullah, Shaker, et al.
Publicado: (2023) -
2-(Phenylsulfanyl)pyridine-3-carboxylic acid
por: Khan, Muhammad Naeem, et al.
Publicado: (2009) -
4-Methoxybenzenecarbothioamide
por: Ali, Saqib, et al.
Publicado: (2010) -
4-Methylbenzenecarbothioamide
por: Ali, Saqib, et al.
Publicado: (2010)